Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sex Differences in Neural Response to Cannabidiol

Next Previous
X
Search
Trial Profile

Sex Differences in Neural Response to Cannabidiol

Status: Recruiting
Phase of Trial: Phase 0

Latest Information Update: 26 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Blepharospasm; Cerebral ischaemia; Dravet syndrome; Duchenne muscular dystrophy; Dyslipidaemias; Epilepsy; Heroin-related disorders; Infantile spasms; Lennox-Gastaut syndrome; Non-alcoholic fatty liver disease; Opioid-related disorders; Ovarian cancer; Parkinson's disease; Pervasive child development disorders; Rett syndrome; Schizophrenia; Sturge-Weber syndrome; Tuberous sclerosis; Type 2 diabetes mellitus; Ulcerative colitis
  • Focus Pharmacodynamics

    • Most Recent Events

    • 13 Jan 2023 Planned number of patients changed from 10 to 20.
    • 13 Jan 2023 Planned End Date changed from 28 Feb 2023 to 28 Feb 2024.
    • 13 Jan 2023 Planned primary completion date changed from 28 Feb 2023 to 28 Feb 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top